homocystinuria

Search with Google Search with Bing
Information
Disease name
homocystinuria
Disease ID
DOID:9263
Description
"An amino acid metabolic disorder that involves an accumulation of homocysteine in the serum and an increased excretion of homocysteine in the urine." [url:http\://en.wikipedia.org/wiki/Homocystinuria]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03406611 Active, not recruiting Phase 1/Phase 2 Pegtibatinase as an Enzyme Therapy for Patients With Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE) January 22, 2019 December 2026
NCT00483314 Completed Phase 2 Homocystinuria: Treatment With N-Acetylcysteine November 2007 February 2009
NCT01192828 Completed Phase 1/Phase 2 Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine January 2010 December 2017
NCT02404337 Completed Phase 2 Betaine METABOLISM OF PATIENTS With Homocystinuria July 2015 February 2018
NCT00004356 Completed Study of Homocysteine Metabolism in Homocystinuria February 1995 October 2000
NCT04021732 Completed Effects of Exercise on Metabolic Parameters in Classical Homocystinuria July 1, 2019 December 1, 2020
NCT05462132 Completed Phase 1 Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers July 7, 2022 November 27, 2022
NCT06431893 Enrolling by invitation Phase 3 A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) April 30, 2024 January 2027
NCT03655223 Enrolling by invitation Early Check: Expanded Screening in Newborns October 15, 2018 December 31, 2025
NCT05051657 Recruiting N/A Evaluation of the Express Plus Range June 14, 2021 April 30, 2025
NCT05687474 Recruiting Baby Detect : Genomic Newborn Screening September 1, 2022 August 31, 2025
NCT05910151 Recruiting Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan October 3, 2022 December 31, 2024
NCT06247085 Recruiting Phase 3 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment December 28, 2023 January 2026
Disase is a (Disease Ontology)
DOID:9252
Cross Reference ID (Disease Ontology)
GARD:10770
Cross Reference ID (Disease Ontology)
ICD10CM:E72.11
Cross Reference ID (Disease Ontology)
MESH:D006712
Cross Reference ID (Disease Ontology)
MIM:236200
Cross Reference ID (Disease Ontology)
MIM:236250
Cross Reference ID (Disease Ontology)
NCI:C84765
Cross Reference ID (Disease Ontology)
ORDO:394
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:190709008
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0019880
Exact Synonym (Disease Ontology)
CBS deficiency
Exact Synonym (Disease Ontology)
cystathionine beta synthase deficiency
Exact Synonym (Disease Ontology)
cystathionine synthase deficiency
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0002156
MeSH unique ID (MeSH (Medical Subject Headings))
D006712